Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells - PubMed (original) (raw)
Affiliations
- PMID: 19148500
Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells
Sachiko Dobashi et al. Oncol Rep. 2009 Feb.
Abstract
In order to clarify the molecular mechanism involved in renal carcinogenesis, and to identify molecular targets for development of novel treatments of renal cell carcinoma (RCC), we previously analyzed genome-wide gene expression profiles of clear-cell types of RCC by cDNA microarray. Among the transcativated genes, we herein focused on functional significance of TMEM22 (transmembrane protein 22), a transmembrane protein, in cell growth of RCC. Northern blot and semi-quantitative RT-PCR analyses confirmed up-regulation of TMEM22 in a great majority of RCC clinical samples and cell lines examined. Immunocytochemical analysis validated its localization at the plasma membrane. We found an interaction between TMEM22 and RAB37 (Ras-related protein Rab-37), which was also up-regulated in RCC cells. Interestingly, knockdown of either of TMEM22 or RAB37 expression by specific siRNA caused significant reduction of cancer cell growth. Our results imply that the TMEM22/RAB37 complex is likely to play a crucial role in growth of RCC and that inhibition of the TMEM22/RAB37 expression or their interaction should be novel therapeutic targets for RCC.
Similar articles
- Microarray gene expression profiling and analysis in renal cell carcinoma.
Liou LS, Shi T, Duan ZH, Sadhukhan P, Der SD, Novick AA, Hissong J, Skacel M, Almasan A, DiDonato JA. Liou LS, et al. BMC Urol. 2004 Jun 22;4:9. doi: 10.1186/1471-2490-4-9. BMC Urol. 2004. PMID: 15212686 Free PMC article. - Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T. Hirota E, et al. Int J Oncol. 2006 Oct;29(4):799-827. Int J Oncol. 2006. PMID: 16964377 - Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, Hamada K, Inayama Y, Kishida T, Hattori K, Yamada-Okabe H, Kubota Y. Yao M, et al. J Pathol. 2005 Feb;205(3):377-87. doi: 10.1002/path.1693. J Pathol. 2005. PMID: 15682440 - Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
Ohno Y, Izumi M, Tachibana M, Kawamura T, Yoshioka K, Aoyagi T, Ohori M, Namiki K, Sakamoto N, Nakagami Y, Hatano T, Akimoto S, Nishimura T. Ohno Y, et al. Oncol Rep. 2008 Sep;20(3):501-9. Oncol Rep. 2008. PMID: 18695898 - MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW, Chang WH, Su YC, Chen YC, Lai YH, Wu PT, Hsu CI, Lin WC, Lai MK, Lin JY. Tang SW, et al. Cancer Lett. 2009 Jan 8;273(1):35-43. doi: 10.1016/j.canlet.2008.07.038. Epub 2008 Sep 21. Cancer Lett. 2009. PMID: 18809243
Cited by
- The Landscape of Transmembrane Protein Family Members in Head and Neck Cancers: Their Biological Role and Diagnostic Utility.
Koteluk O, Bielicka A, Lemańska Ż, Jóźwiak K, Klawiter W, Mackiewicz A, Kazimierczak U, Kolenda T. Koteluk O, et al. Cancers (Basel). 2021 Sep 22;13(19):4737. doi: 10.3390/cancers13194737. Cancers (Basel). 2021. PMID: 34638224 Free PMC article. - TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma.
Duan J, Qian Y, Fu X, Chen M, Liu K, Liu H, Yang J, Liu C, Chang Y. Duan J, et al. Aging (Albany NY). 2021 Feb 11;13(4):5585-5606. doi: 10.18632/aging.202487. Epub 2021 Feb 11. Aging (Albany NY). 2021. PMID: 33591950 Free PMC article. - Distinguishing Glioblastoma Subtypes by Methylation Signatures.
Zhang YH, Li Z, Zeng T, Pan X, Chen L, Liu D, Li H, Huang T, Cai YD. Zhang YH, et al. Front Genet. 2020 Nov 24;11:604336. doi: 10.3389/fgene.2020.604336. eCollection 2020. Front Genet. 2020. PMID: 33329750 Free PMC article. - TMEM213 as a novel prognostic and predictive biomarker for patients with lung adenocarcinoma after curative resection: a study based on bioinformatics analysis.
Zou J, Li Z, Deng H, Hao J, Ding R, Zhao M. Zou J, et al. J Thorac Dis. 2019 Aug;11(8):3399-3410. doi: 10.21037/jtd.2019.08.01. J Thorac Dis. 2019. PMID: 31559044 Free PMC article. - Cancer Stem Cells: Emergent Nature of Tumor Emergency.
Efremov YR, Proskurina AS, Potter EA, Dolgova EV, Efremova OV, Taranov OS, Ostanin AA, Chernykh ER, Kolchanov NA, Bogachev SS. Efremov YR, et al. Front Genet. 2018 Nov 16;9:544. doi: 10.3389/fgene.2018.00544. eCollection 2018. Front Genet. 2018. PMID: 30505319 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases